Xconomy’s Digital Events →
David Schenkein is the CEO of Agios Pharmaceuticals.
Sponsored · Whitepaper
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.